Novartis readies for FDA review of $1 bln CAR-T child cancer hope – Reuters
|
Novartis readies for FDA review of $1 bln CAR–T child cancer hope
Reuters "Our first tests convinced us these T cells were special," Campana, now a scientist at the National University Cancer Institute in Singapore, told Reuters by email this week. "I had never seen any drug killing leukemic cells so rapidly and specifically.". |
